Department of Neurosurgery, The University of Tokyo, Tokyo, Japan; Department of Neurosurgery, The Fourth Affiliated Hospital of School of Medicine and International School of Medicine, International Institutes of Medicine, Zhejiang University, Zhejiang, China.
Department of Neurosurgery, The University of Tokyo, Tokyo, Japan.
World Neurosurg. 2024 Sep;189:e814-e824. doi: 10.1016/j.wneu.2024.07.010. Epub 2024 Jul 7.
OBJECTIVE: This study compared the effectiveness of the endoscopic endonasal approach (EEA) with the conventional transcranial approach (TCA) for treating tuberculum sellae meningiomas (TSMs), aiming to identify the superior surgical method and the risk factors affecting outcomes. METHODS: Patients treated for TSM from 1998 to 2023 at our institution were retrospectively analyzed, evaluating patient characteristics, tumor features, outcomes, and complications. A novel grading system for preoperative evaluation of TSMs was proposed. RESULTS: Among 49 patients, 26 underwent EEA and 23 underwent TCA. The maximum diameters were comparable between the groups (mean 22 mm vs. 23 mm). Gross total resection rates were 62% for EEA and 70% for TCA, showing no significant difference. However, postsurgical visual improvement was significantly higher in the EEA group compared with the TCA group (77% vs. 44%; P = 0.020), with fewer complications in the EEA group (8% vs. 35%; P = 0.032). CONCLUSIONS: EEA is a safe and effective treatment approach for small to medium TSMs, with outcomes comparable to TCA in terms of resection but superior in visual improvement and fewer complications. Selection of surgical approach should consider patient and tumor characteristics as well as surgeon experience.
目的:本研究旨在比较经鼻内镜颅底入路(EEA)与传统经颅入路(TCA)治疗鞍结节脑膜瘤(TSMs)的疗效,以确定更优的手术方法和影响疗效的相关因素。
方法:回顾性分析了 1998 年至 2023 年在我院接受治疗的 TSM 患者的临床资料,评估患者特征、肿瘤特征、手术结果和并发症。提出了一种新的 TSM 术前评估分级系统。
结果:49 例患者中,26 例行 EEA,23 例行 TCA。两组患者肿瘤最大直径相似(平均 22mm 比 23mm)。EEA 组和 TCA 组的肿瘤全切率分别为 62%和 70%,差异无统计学意义。但 EEA 组术后视力改善明显优于 TCA 组(77%比 44%;P=0.020),EEA 组并发症发生率明显低于 TCA 组(8%比 35%;P=0.032)。
结论:对于中小型 TSMs,EEA 是一种安全有效的治疗方法,其切除效果与 TCA 相当,但在视力改善和并发症方面具有优势。手术入路的选择应综合考虑患者和肿瘤特征以及术者经验。